Feed 6620.TWO
66
Handa Pharmaceuticals, Inc.
6620.TWO · TWO
$78.10 -3.34% (-$2.70)
1M -13.42%
Market Cap $13.5B
P/E Ratio 17.95x
Div. Yield 2.57%
ROE 16.45%
Bulios Fair Price
$56.33
27.9% downside
Trenutna cena
$78.1
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica 6620.TWO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Valuation
47 /100
Fair P/E 17.95x
EV/EBITDA 12.52x
PEG 0.31x
Growth
100 /100
Growing Rev. growth 106.05%
Book val. growth 98.74%
EPS growth N/A
Profitability
94 /100
Strong Gross margin 84.53%
Net margin 43.36%
FCF margin 13.10%
Quality
70 /100
Excellent ROIC 12.92%
ROE 16.45%
Asset turnover 0.29x
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 36.59x
Net debt/EBITDA -1.88x
Stability
33 /100
Unstable Beta 0.70x
Rev. volatility 250.36%
Profitable years 3
Vprašajte StockBota o 6620.TWO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Fang-Yu Liu
Employees
15
Headquarters
Tainan City
Prihajajoči dogodki
19 AVG.
Earnings
Upcoming earnings report
13 NOV.
Earnings
Upcoming earnings report